Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 40 pages - $500
Nov 2011 - 7 pages - $3,835
Jun 2006 - 1458 pages - $2,495
Oct 2009 - 17 pages - $500
Oct 2011 - 150 pages - $3,500
Dec 2010 - 28 pages - $500
Mar 2011 - 32 pages - $250
Mar 2010 - 39 pages - $2,000
Feb 2011 - 26 pages - $1,000
Apr 2011 - $75
Your selection
Browse By
- Industry sector
- Advertising
- Business services
- Clinical research
- Communications
- Consultancy
- Distribution
- Event management
- Finance
- Information technology
- Laboratory equipment
- Legal
- Manufacturing
- Market research
- Marketing
- Materials
- Medical education
- Packaging
- Patents
- Pharmacovigilance
- Product development
- Public relations
- Publishers
- Recruitment
- Regulatory affairs
- Research
- Training
- Therapeutic target
- Bacteria or virus
- Bioterrorism
- Diseases
- Hepatitis (other)
- Nosocomial infections
- Parasitic diseases
- Treatments
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us